126 related articles for article (PubMed ID: 29966468)
21. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
[TBL] [Abstract][Full Text] [Related]
22. Management of marginal zone lymphoma.
Reid R; Friedberg JW
Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
[No Abstract] [Full Text] [Related]
23. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.
Behdad A; Bailey NG
Arch Pathol Lab Med; 2014 Oct; 138(10):1295-301. PubMed ID: 25268192
[TBL] [Abstract][Full Text] [Related]
25. BRAF
Vaughn JL; Freitag CE; Hemminger JA; Jones JA
J Med Case Rep; 2017 Apr; 11(1):92. PubMed ID: 28376906
[TBL] [Abstract][Full Text] [Related]
26. Epidermotropic CXCR3 positive marginal zone lymphoma: a distinctive clinical histopathological entity potentially originating in the skin; it does not always indicate splenic marginal zone lymphoma.
Magro CM; Momtahen S; Coleman M; Grossman ME
Dermatol Online J; 2019 Jul; 25(7):. PubMed ID: 31450275
[TBL] [Abstract][Full Text] [Related]
27. Clinical and diagnostic relevance of
Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
[No Abstract] [Full Text] [Related]
28. Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.
Pata G; Damiani E; Bartoli M; Solari S; Anastasia A; Pagani C; Tucci A; Ragni F
Leuk Lymphoma; 2016; 57(6):1467-70. PubMed ID: 26373930
[No Abstract] [Full Text] [Related]
29. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
Robinson AC; Nachar VR
J Oncol Pharm Pract; 2020 Jul; 26(5):1248-1253. PubMed ID: 31766968
[TBL] [Abstract][Full Text] [Related]
30. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
[TBL] [Abstract][Full Text] [Related]
31. [Splenic marginal zone lymphoma uncovered after a 10-year follow up as anemia of unknown cause].
Koyama A; Shiotani C; Kurihara T; Mushino T; Okamoto Y; Tamaki T; Ozaki T; Ohshima K; Tamura S
Rinsho Ketsueki; 2017; 58(1):9-14. PubMed ID: 28190866
[TBL] [Abstract][Full Text] [Related]
32. Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema.
Motosue MS; Howard MT; Butterfield JH
Ann Allergy Asthma Immunol; 2016 May; 116(5):472-3. PubMed ID: 27017557
[No Abstract] [Full Text] [Related]
33. Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report.
Kakinoki Y; Kubota H; Sakurai H; Sato T; Tokusashi Y
Int J Hematol; 2005 Jun; 81(5):417-20. PubMed ID: 16158823
[TBL] [Abstract][Full Text] [Related]
34. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
Sbattella M; Zanichelli A; Ghia P; Gattei V; Suffritti C; Teatini T; Cicardi M; Castelli R
Med Oncol; 2018 Aug; 35(9):118. PubMed ID: 30073422
[TBL] [Abstract][Full Text] [Related]
35. CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL).
Kyrtsonis MC; Levidou G; Korkolopoulou P; Koulieris E; Bartzi V; Maltezas D; Pangalis GA; Kalpadakis C; Dimou M; Georgiou G; Vassilakopoulos TP; Angelopoulou MK; Salpeas V; Tsaftaridis P; Patsouris E; Panayiotidis P; Tzenou TK
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):99-102. PubMed ID: 21454203
[TBL] [Abstract][Full Text] [Related]
36. Membranous glomerulonephritis associated with splenic marginal zone lymphoma mimicking multiple myeloma.
Silva GE; Costa RS; Chahud F; Neto OM; Moyses-Neto M; Romão EA; Dantas M
Clin Nephrol; 2013 Jun; 79(6):488-93. PubMed ID: 23725648
[TBL] [Abstract][Full Text] [Related]
37. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
38. [49-year-old woman with leukocytosis and splenomegaly].
Austein T; Meinecke G
Dtsch Med Wochenschr; 2011 Oct; 136(43):2197-8. PubMed ID: 22009173
[No Abstract] [Full Text] [Related]
39. [Splenic lymphoma of the marginal zone without peripheral hairy lymphocytes].
Pila Pérez R; Pila Peláez R; Rosales Torres P; Holguín Prieto VA; Alzate Giraldo LF
An Med Interna; 2007 Aug; 24(8):396-8. PubMed ID: 18020882
[TBL] [Abstract][Full Text] [Related]
40. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]